Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
UBS
Fuji
Colorcon
Express Scripts
Medtronic
Harvard Business School
Moodys
Johnson and Johnson

Generated: June 22, 2018

DrugPatentWatch Database Preview

MAXAIR Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Maxair patents expire, and what generic alternatives are available?

Maxair is a drug marketed by Medicis and Valeant Pharms and is included in two NDAs.

The generic ingredient in MAXAIR is pirbuterol acetate. There are three drug master file entries for this compound. Additional details are available on the pirbuterol acetate profile page.
Summary for MAXAIR
Drug patent expirations by year for MAXAIR
Synonyms for MAXAIR
2-(HYDROXYMETHYL)-6-(1-HYDROXY-2-TERT-BUTYLAMINO-ETHYL)-PYRIDIN-3-OL
2,6-Pyridinedimethanol, alpha(sup 6)-(((1,1-dimethylethyl)amino)methyl)-3-hydroxy-, monoacetate (salt)
38677-81-5 (Parent)
6-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)pyridin-3-ol acetate salt
65652-44-0
AC1L57YJ
acetic acid; 6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol
ACETIC ACID; PIRBUTEROL
AK316130
AKOS027323719
alpha(sup 6)-((tert-Butylamino)methyl)-3-hydroxy-2,6-pyridinedimethanol monoacetate (salt)
alpha6-((tert-Butylamino)methyl)-3-hydroxypyridine-2,6-dimethanol monoacetate
C12H20N2O3.C2H4O2
CHEBI:8246
CHEMBL1200444
CP-24314-14
CP-2431414
D00686
EINECS 265-862-4
HE059718
HE376047
LS-176467
Maxair (TN)
Pirbuterol acetate
Pirbuterol acetate (USAN)
Pirbuterol acetate [USAN]
Pirbuterol acetate, United States Pharmacopeia (USP) Reference Standard
Pirbuterol acetate, VETRANAL(TM), analytical standard
SCHEMBL3600

US Patents and Regulatory Information for MAXAIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 020014-001 Nov 30, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 019009-001 Dec 30, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for MAXAIR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 019009-001 Dec 30, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Medicis MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 020014-001 Nov 30, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 019009-001 Dec 30, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 019009-001 Dec 30, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
McKinsey
US Department of Justice
Express Scripts
Federal Trade Commission
Merck
Fish and Richardson
Julphar
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.